Showing all 3 results
Buprenorphine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Compressed Sublingual Tablet, engineered for rapid mucosal absorption.
Active Ingredient Strength Primary Clinical Function Buprenorphine HCl USP/Ph.Eur. 0.4 mg / 2 mg The Pain & Induction Anchor: Low-dose format for chronic pain or the initial phase of addiction treatment. Buprenorphine HCl USP/Ph.Eur. 8 mg The Maintenance Payload: High-strength dose for long-term stabilization in Opioid Use Disorder. Excipients Sublingual Matrix Rapid Dissolution System: Engineered to dissolve completely under the tongue in < 2 minutes for maximum transmucosal bioavailability. Codeine Phosphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Narcotic Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the alkaloid salt and to strictly prevent diversion.
Active Ingredient Strength Primary Clinical Function Codeine Phosphate USP/Ph.Eur. 15 mg / 30 mg The Standard Analgesic / Antitussive Anchor: The definitive unit utilized for the suppression of severe, dry coughs and the management of mild-to-moderate acute somatic pain. Codeine Phosphate USP/Ph.Eur. 60 mg The Severe Trauma Macrodose: The heavy therapeutic payload utilized strictly for moderate-to-severe refractory pain, often in post-operative or palliative oncology settings. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Magnesium Stearate / Colloidal Silicon Dioxide Diluent / Densifier / Superdisintegrant / Lubricant / Glidant (Engineered utilizing Strict Geometric Dilution to ensure the opiate payload is flawlessly uniform across every batch, preventing toxic “hot spots” that could trigger accidental respiratory depression) *Pack Sizes: 10×10 Tamper-Evident Blisters (Optimized specifically for strict, closely monitored acute pain dispensing regimens).
Morphine Sulphate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Morphine Sulphate USP/Ph.Eur. 15 mg (SR) Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management. Morphine Sulphate USP/Ph.Eur. 30 mg / 60 mg (SR) Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain. Excipients Hypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded Film Hydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).
